DK238588A - Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes - Google Patents

Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes

Info

Publication number
DK238588A
DK238588A DK238588A DK238588A DK238588A DK 238588 A DK238588 A DK 238588A DK 238588 A DK238588 A DK 238588A DK 238588 A DK238588 A DK 238588A DK 238588 A DK238588 A DK 238588A
Authority
DK
Denmark
Prior art keywords
trifluormethylphenoxy
phenylpropylamine
medicine
methyl
preparation
Prior art date
Application number
DK238588A
Other languages
Danish (da)
English (en)
Other versions
DK238588D0 (da
Inventor
David Taiwai Wong
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK238588D0 publication Critical patent/DK238588D0/da
Publication of DK238588A publication Critical patent/DK238588A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK238588A 1987-05-04 1988-05-03 Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes DK238588A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4550987A 1987-05-04 1987-05-04

Publications (2)

Publication Number Publication Date
DK238588D0 DK238588D0 (da) 1988-05-03
DK238588A true DK238588A (da) 1988-11-05

Family

ID=21938301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK238588A DK238588A (da) 1987-05-04 1988-05-03 Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes

Country Status (11)

Country Link
EP (1) EP0294028B1 (xx)
JP (1) JP2721507B2 (xx)
KR (1) KR880013555A (xx)
AT (1) ATE93721T1 (xx)
AU (1) AU596296B2 (xx)
DE (1) DE3883606T2 (xx)
DK (1) DK238588A (xx)
ES (1) ES2058272T3 (xx)
HK (1) HK19595A (xx)
PH (1) PH23901A (xx)
ZA (1) ZA883115B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA912277B (en) * 1990-03-29 1992-11-25 Lilly Co Eli The selective occupation of serotonin ic receptors
US5589511A (en) * 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
US5708035A (en) * 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
US7034059B2 (en) 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
PT2316456T (pt) 2003-04-29 2017-09-05 Orexigen Therapeutics Inc Composições para afetar a perda de peso compreendendo naltrexona e bupropion
ES2761812T3 (es) 2005-11-22 2020-05-21 Nalpropion Pharmaceuticals Inc Composición y métodos de aumento de la sensibilidad a la insulina
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
ATE460925T1 (de) 2006-11-09 2010-04-15 Orexigen Therapeutics Inc Mehrschichtige pharmazeutische formulierungen mit einer schnell auflösenden zwischenschicht
CA2668885C (en) 2006-11-09 2016-08-02 Orexigen Therapeutics, Inc. Methods for administering weight loss medications
CA2725930A1 (en) 2008-05-30 2009-12-30 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
KR101841442B1 (ko) 2010-01-11 2018-03-23 오렉시젠 세러퓨틱스 인크. 주우울증 환자들에 있어서 체중 감량 치료를 제공하는 방법
EP2858640B1 (en) 2012-06-06 2020-03-25 Nalpropion Pharmaceuticals LLC Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk
US20150174083A1 (en) 2012-07-31 2015-06-25 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Use of fluoxetine for increasing meat and milk production
EP2879516A1 (en) 2012-07-31 2015-06-10 Sanovel Hayvan Sagligi Ürünleri Sanayi ve Ticaret A.S. Use of fluoxetine in animals
US8969371B1 (en) 2013-12-06 2015-03-03 Orexigen Therapeutics, Inc. Compositions and methods for weight loss in at risk patient populations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4626549A (en) * 1974-01-10 1986-12-02 Eli Lilly And Company Treatment of obesity with aryloxyphenylpropylamines
US4590213A (en) * 1983-04-08 1986-05-20 Eli Lilly And Company Anti-anxiety method
CA1267092A (en) * 1985-02-25 1990-03-27 Martin D. Hynes Analgesic composition containing codeine

Also Published As

Publication number Publication date
AU1553388A (en) 1988-11-10
PH23901A (en) 1989-12-18
ES2058272T3 (es) 1994-11-01
ATE93721T1 (de) 1993-09-15
DK238588D0 (da) 1988-05-03
HK19595A (en) 1995-02-17
JPS63284126A (ja) 1988-11-21
DE3883606D1 (de) 1993-10-07
KR880013555A (ko) 1988-12-21
EP0294028A2 (en) 1988-12-07
JP2721507B2 (ja) 1998-03-04
EP0294028B1 (en) 1993-09-01
DE3883606T2 (de) 1994-01-20
AU596296B2 (en) 1990-04-26
ZA883115B (en) 1990-01-31
EP0294028A3 (en) 1990-05-02

Similar Documents

Publication Publication Date Title
DK238588A (da) Anvendelse af 3-(trifluormethylphenoxy)-n-methyl-3-phenylpropylamin til fremstilling af et laegemiddel til behandling af diabetes
DK162965C (da) Anvendelse af et difluornucleosid eller et farmaceutisk acceptabelt salt deraf til fremstilling af et laegemiddel til behandling af neoplasma
FI883757A0 (fi) Terapeutiska nukleosider.
NO875022D0 (no) Apparat for medisinsk diagnostisering.
IT8104812A0 (it) Ago ipodermico.
DK159476C (da) Apparat til medicinsk behandling
ATE119772T1 (de) Bilobalid zur anwendung als therapeutischer wirkstoff.
NO168985C (no) Anordning ved stol.
NO872924D0 (no) Fibere inneholdende legemiddel for kontrollert frigjoering.
DE3850471D1 (de) Automatischer Apparat zur heilenden Hydromassage.
FI881651A0 (fi) Terapeutiska nukleosider.
DK49488A (da) Anaestesi-praeparat
DK69983A (da) Koblingsanordning til styring af en indstillingsindretnings bevaegelse, navnlig en patientstol
DK472688D0 (da) Anvendelse af bezafibrat til behandling af diabetes
DK369385D0 (da) Middel til behandling af schizofreni
IT8322773A0 (it) Perfezionamenti alle lenti all'infrarosso.
DK440288D0 (da) Middel til behandling af diabetes mellitus
DE3854179D1 (de) Vulkanisierbare Fluorkautschukzusammensetzung.
DE3888869D1 (de) Polyimidharz-Zusammensetzung.
ES2019634B3 (es) Terapia con clorfeniramina.
DK591787A (da) Anvendelse af 5-(substitueret phenyl)-oxa-zolidinonderivater til fremstilling af et til behandling af depressioner egnet laegemiddel
FI881216A0 (fi) Terapeutiska nukleosider.
NO864320D0 (no) Harpiksblanding istand til aa avgi et bioaktivt stoff med kontrollert hastighet.
IT8719036A0 (it) Composizione terapeutica per complicazioni diabetiche.
KR890004654U (ko) 해밍용 프레스 금형의 구조

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment